Posted in | News | Imaging

First Production Electro-Optical Targeting System Delivered to Lockheed Martin Aeronautics

Lockheed Martin (NYSE: LMT) has marked successful entry into low rate initial production on the F-35 Lightning II Electro-Optical Targeting System (EOTS). The first production units have been delivered to Lockheed Martin Aeronautics in Fort Worth, TX, for integration onto the aircraft.

F-35 Lightning II Electro-optical Targeting System

Embedded into the F-35's fuselage with an innovative faceted sapphire window, the low-drag, stealthy EOTS is the world's first and only sensor combining forward-looking infrared and infrared search and track functionality. The F-35 EOTS will provide Lightning II pilots with significant air-to-air and air-to-ground situational awareness in a single compact and completely passive sensor.

"Our team looks forward to meeting its commitment to provide a superior targeting system to F-35 pilots around the world as we gear up to produce more than 3,000 units," said Rich Hinkle, program director of F-35 Lightning II EOTS at Lockheed Martin Missiles and Fire Control. "This delivery marks a pivotal achievement for the EOTS as we transition from a system design and development program to a production program."

The F-35 EOTS production is ramping up to produce up to 200 units a year. "The outlook for the F-35 program is very strong," Hinkle said. "Our success in supporting the program is vital to the F-35's mission to provide dominant airpower across the full air-to-air, air-to-ground mission spectrum."

The latest generation infrared sensor technology, the F-35 EOTS builds upon the success of Lockheed Martin's Sniper(®) Advanced Targeting Pod to provide high-resolution imagery, automatic target tracking, infrared-search-and-track, laser designation and range finding, as well as laser spot tracking--all at greatly increased standoff ranges. Modular components allow the F-35 EOTS to be maintained on the flight line for true two-level maintenance.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.